Activation of the aryl hydrocarbon receptor affects activation and function of human monocyte-derived dendritic cells

Clinical and Experimental Immunology

Volumn 177, Issue 2, 2014, Pages 521-530

  Wang, C ^a   Ye, Z ^a   Kijlstra, A ^b   Zhou, Y ^a   Yang, P ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aryl hydrocarbon receptor (AhR); Beh et's disease; DCs; FICZ; ITE

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ARYL HYDROCARBON RECEPTOR (AHR); BEHÇET'S DISEASE; DCS; FICZ; ITE;

ADULT; ANTIGENS, CD80; ANTIGENS, CD86; BEHCET SYNDROME; CARBAZOLES; CASE-CONTROL STUDIES; CYTOKINES; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; INDOLES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ARYL HYDROCARBON; TH1 CELLS; TH17 CELLS; THIAZOLES; YOUNG ADULT;

EID: 84904013311     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12352     Document Type: Article

References (52)

1. Gu YZ, Hogenesch JB, Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000; 40:519-561.
2. Fujii-Kuriyama Y, Kawajiri K. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86:40-53.
3. Quintana FJ, Basso AS, Iglesias AH etal. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65-71.
4. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009; 30:447-454.
5. Kimura A, Naka T, Nakahama T etal. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 2009; 206:2027-2035.
6. Song J, Clagett-Dame M, Peterson RE etal. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 2002; 99:14694-14699.
7. Quintana FJ, Murugaiyan G, Farez MF etal. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010; 107:20768-20773.
8. Bonfioli AA, Orefice F. Behcet's disease. Semin Ophthalmol 2005; 20:199-206.
9. Hamzaoui K. Th17 cells in Behcet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011; 29:S71-76.
10. Chi W, Zhu X, Yang P etal. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49:3058-3064.
11. Geri G, Terrier B, Rosenzwajg M etal. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol 2011; 128:655-664.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
13. Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013; 13:566-577.
14. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007; 117:1119-1127.
15. Flores-Romo L. In vivo maturation and migration of dendritic cells. Immunology 2001; 102:255-262.
16. Harry RA, Anderson AE, Isaacs JD, Hilkens CM. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 2010; 69:2042-2050.
17. Klechevsky E, Banchereau J. Human dendritic cells subsets as targets and vectors for therapy. Ann NY Acad Sci 2013; 1284:24-30.
18. Lee CN, Lew AM, Wu L. The potential role of dendritic cells in the therapy of Type 1 diabetes. Immunotherapy 2013; 5:591-606.
19. International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078-1080.
20. Wang C, Tian Y, Lei B etal. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2012; 53:4668-4675.
21. Sarkar S, Perlstein EO, Imarisio S etal. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3:331-338.
22. Ho TC, Yang YC, Chen SL etal. Pigment epithelium-derived factor induces THP-1 macrophage apoptosis and necrosis by the induction of the peroxisome proliferator-activated receptor gamma. Mol Immunol 2008; 45:898-909.
23. Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 2010; 159:11-22.
24. Nugent LF, Shi G, Vistica BP, Ogbeifun O, Hinshaw SJ, Gery I. ITE, a novel endogenous nontoxic aryl hydrocarbon receptor ligand, efficiently suppresses EAU and T-cell-mediated immunity. Invest Ophthalmol Vis Sci 2013; 54:7463-7469.
25. Zhang L, Ma J, Takeuchi M etal. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci 2010; 51:2109-2117.
26. Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J Immunol 2009; 183:66-74.
27. Veldhoen M, Hirota K, Westendorf AM etal. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453:106-109.
28. Monteleone I, Rizzo A, Sarra M etal. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011; 141:237-248, 48 e1.
29. Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004; 20:539-550.
30. Vezys V, Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 2002; 169:6677-6680.
31. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007; 27:417-424.
32. Pedersen AE, Schmidt EG, Gad M, Poulsen SS, Claesson MH. Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model. Immunology 2009; 127:354-364.
33. Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 2008; 67 (Suppl. 3):iii90-96.
34. Bankoti J, Rase B, Simones T, Shepherd DM. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol Appl Pharmacol 2010; 246:18-28.
35. Kobayashi S, Okamoto H, Iwamoto T etal. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxf) 2008; 47:1317-1322.
36. Yang Y, Qi J, Wang Q etal. Berberine suppresses Th17 and dendritic cell responses. Invest Ophthalmol Vis Sci 2013; 54:2516-2522.
37. Zhou Q, Xiao X, Wang C etal. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome. Invest Ophthalmol Vis Sci 2012; 53:5665-5674.
38. Tian Y, Wang C, Ye Z, Xiao X, Kijlstra A, Yang P. Effect of 1, 25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behcet's disease. Invest Ophthalmol Vis Sci 2012; 53:6434-6441.
39. Xu Y, Zhu KJ, Chen XZ, Zhao KJ, Lu ZM, Cheng H. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11. Arch Dermatol Res 2008; 300:235-242.
40. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-2411.
41. Granucci F, Ferrero E, Foti M, Aggujaro D, Vettoretto K, Ricciardi-Castagnoli P. Early events in dendritic cell maturation induced by LPS. Microbes Infect 1999; 1:1079-1084.
42. De Smedt T, Pajak B, Muraille E etal. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996; 184:1413-1424.
43. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 2007; 21:2941-2955.
44. Vogel CF, Wu D, Goth SR etal. Aryl hydrocarbon receptor signaling regulates NF-kappaB RelB activation during dendritic-cell differentiation. Immunol Cell Biol 2013; 91:568-575.
45. Shih VF, Davis-Turak J, Macal M etal. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nat Immunol 2012; 13:1162-1170.
46. Clark GJ, Gunningham S, Troy A, Vuckovic S, Hart DN. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999; 98:189-196.
47. Ramirez JM, Brembilla NC, Sorg O etal. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 2010; 40:2450-2459.
48. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 2008; 105:9721-9726.
49. Quintana FJ, Basso AS, Iglesias AH etal. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65-71.
50. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 2009; 206:43-49.
51. Duarte JH, Di Meglio P, Hirota K, Ahlfors H, Stockinger B. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLOS ONE 2013; 8:e79819.
52. Veldhoen M, Duarte JH. The aryl hydrocarbon receptor: fine-tuning the immune-response. Curr Opin Immunol 2010; 22:747-752.